Top Employee Participation Stories
10,000 patients have filed 'gastro' claims against Ozempic, Mounjaro drug makers
By Gregg GoldfarbPatients who have experienced severe stomach complications from the new class of GLP-1 weight loss drugs are now suing Novo Nordisk and Eli Lilly alleging that the drugmakers misled doctors on the drugs' potential risks.










